Duavive trial for mood and anxiety in midlife women
Part of Mental health clinical trials.
This Phase 1 study tests Duavive’s effects on mood and anxiety symptoms in women going through perimenopause or early menopause. It may help clarify whether this treatment can reduce depression and/or anxiety symptoms in midlife.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 45 to 60
- You can speak and understand English
- You are in perimenopause or early menopause (within 10 years after your last period)
- Your depression or anxiety scores are high (CES-D-10 ≥10 and/or GAD-7 ≥10)
- You have not had certain cancers (breast, ovarian, or endometrial) and don’t have endometrial overgrowth
- You don’t have major exclusion conditions like blood clots, active liver disease, or uncontrolled high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily multivitamin and mineral supplement can improve mental and emotional well-being, especially for people going through perimenopausal symptoms. You would take the supplement daily and track your sleep and activity with a smart ring.
This trial is testing a new non-hormonal gel for vaginal dryness and discomfort after menopause. It aims to see if the gel improves quality of life.
This trial studies ways to help women during the late menopausal transition. It uses a smartphone app and telehealth visits to track your health and help you feel better.
This study tests whether a natural herb called Shatavari can help with menopausal symptoms like hot flashes, sleep problems, and mood changes. It compares Shatavari to a placebo (a pill with no active ingredient) to see if it is safe and effective.
This trial studies whether simvastatin and Duavee can improve endometriosis-related symptoms linked to small blood-vessel problems. You may be eligible if you’re a woman aged 18–45 with confirmed endometriosis and meet safety requirements.
This trial tests whether allopregnanolone, a natural brain chemical, can help depression in women going through menopause. It compares the effects against a placebo to see if it improves mood symptoms.
Hear when a new Menopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.